Tag Archives: LXRP

Best Financial Stocks To Watch For 2018

President Donald Trump appeared to confirm that his summit with Kim Jong Un was back on, three days after he abruptly called off the historic meeting in an sharply worded letter to the North Korean leader.

“Our United States team has arrived in North Korea to make arrangements for the Summit between Kim Jong Un and myself,” Trump said in tweet on Sunday afternoon, making no reference to his recent decision to pull out of the meeting.

“I truly believe North Korea has brilliant potential and will be a great economic and financial Nation one day,” Trump added. “Kim Jong Un agrees with me on this. It will happen!”

#lazy-img-328044342:before{padding-top:66.66666666666666%;}

Mike Pompeo

Best Financial Stocks To Watch For 2018: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By ]

    Here is the list of the cannabis companies that we track.

    Name Currency Ticker Canopy Growth Corp. CAD (CGC) Aurora Cannabis Inc. CAD (ACBFF) Aphria Inc. CAD (APHQF) MedReleaf Corp. CAD (OTCPK:MEDFF) Cronos Group CAD (CRON) The Green Organic Dutchman CAD (OTC:TGODF) CannTrust CAD (OTC:CNTTF) Hydropothecary Corp/The CAD (HYYDF) Cannabis Wheaton Income CAD (OTCQB:CBWTF) Emerald Health Therapeutics Inc. CAD (OTCQX:EMHTF) Organigram Holdings Inc. CAD (OTCQB:OGRMF) TerrAscend Corp. CAD (OTC:TRSSF) Supreme Cannabis Co Inc./The CAD (OTCPK:SPRWF) Hiku Brands CAD (OTCPK:DJACF) ABcann Global Corp. CAD (OTCQB:ABCCF) Radient Technologies Inc. CAD (OTC:RDDTF) Village Farms International Inc. CAD (OTCQX:VFFIF) Namaste Technologies CAD (OTCQB:NXTTF) MPX Bioceutical Corp. CAD (OTCQB:MPXEF) Sunniva CAD (OTCQX:SNNVF) MYM Nutraceuticals Inc. CAD (OTCQB:MYMMF) Maricann Group Inc. CAD (OTCQB:MRRCF) Cannabix Technologies Inc. CAD (OTCPK:BLOZF) THC Biomed INTL. Ltd. CAD (OTCQB:THCBF) ICC Labs Inc. CAD (OTC:ICCLF) WeedMD Inc. CAD (OTCPK:WDDMF) CannaRoyalty Corp. CAD (OTCQX:CNNRF) InMed Pharmaceuticals Inc. CAD (OTCQX:IMLFF) Harvest One Cannabis Inc. CAD (OTC:HRVOF) Golden Leaf Holdings Inc. CAD (OTCQB:GLDFF) Benchmark Botanics Inc. CAD (OTCPK:BHHKF) Friday Night Inc. CAD (OTCQB:TGIFF) Valens Groworks Corp. CAD (OTC:MYMSF) Invictus MD CAD (IVITF) Emblem Corp. CAD (OTCPK:EMMBF) Tetra Bio-Pharma Inc. CAD (OTCQB:TBPMF) Maple Leaf Green World Inc. CAD (OTCQB:MGWFF) Delta 9 Cannabis Inc. CAD (OTC:VRNDF) Nutritional High International Inc. CAD (OTCQB:SPLIF) Lifestyle Delivery Systems Inc. CAD (OTCQX:LDSYF) Marapharm Ventures Inc. CAD (OTCQX:MRPHF) Wildflower Marijuana Inc. CAD (OTC:WLDFF) Indiva Ltd. CAD (OTC:RMKXD) Hempco Food And Fiber Inc. CAD (OTC:HMPPF) PUF Ventures Inc. CAD (OTCPK:PUFXF) Liberty Leaf Holdings CAD (OTCQB:LIBFF) Canada House Welln

Best Financial Stocks To Watch For 2018: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Strategy Asset Managers LLC acquired a new stake in Avery Dennison (NYSE:AVY) during the first quarter, HoldingsChannel.com reports. The firm acquired 23,500 shares of the industrial products company’s stock, valued at approximately $2,497,000.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Avery Dennison alerts:

    Avery Dennison (AVY) Shares Cross Below 200 DMA (nasdaq.com) Avery Dennison (AVY) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Concern in Framingham about environmental contamination (metrowestdailynews.com) Avery Dennison (AVY) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com) Avery Dennison (AVY) Upgraded at Zacks Investment Research (americanbankingnews.com)

    Several equities research analysts recently commented on AVY shares. Citigroup dropped their price objective on Avery Dennison from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Thursday, April 5th. Zacks Investment Research raised Avery Dennison from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research report on Monday, February 5th. UBS started coverage on Avery Dennison in a research report on Thursday, January 18th. They set a “buy” rating and a $135.00 price objective on the stock. Bank of America increased their price objective on Avery Dennison from $128.00 to $133.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of Avery Dennison in a research report on Wednesday, April 25th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $123.00.

Best Financial Stocks To Watch For 2018: CACI International, Inc.(CACI)

Advisors’ Opinion:

  • [By Max Byerly]

    Travelzoo (NASDAQ: TZOO) and CACI (NYSE:CACI) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

what is share market

You could call them rebel girls themselves.

The authors behind the best-selling children’s book “Good Night Stories for Rebel Girls” are once again putting a modern spin on fairy tales with a collection of real-life female super heroes.

The book, which debuted in 2016, featured 100 stories about the lives of women, from Queen Elizabeth I to Serena Williams.

Now, “Good Night Stories for Rebel Girls Volume 2” — due out November 20 — builds on what they first started. It includes another 100 stories of female scientists, engineers, judges and painters to encourage young girls to grow up to be and do whatever they choose.

Among those featured are teenage eagle hunter Aisholpan Nurgaiv; the NASA women who inspired the film “Hidden Figures” (Katherine Johnson, Dorothy Vaughan and Mary Jackson); and “Frankenstein” author Mary Shelley.

The stories come from all over the world, including China, North Korea and the Sudan.

Like with the first book, all visuals are drawn by female illustrators.

what is share market: Alere Inc.(ALR)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, healthcare shares fell by 0.91 percent. Meanwhile, top losers in the sector included Alere Inc (NYSE: ALR), down 8 percent, and Exelixis, Inc. (NASDAQ: EXEL), down 10 percent.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

what is share market: Caterpillar, Inc.(CAT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    And while big gains from likes of Caterpillar (CAT) weren’t enough to push the S&P 500 over 2,400, that could change soon, write JPMorgan’s Jason Hunter and Alix Tepper. They explain why:

  • [By Chris Dier-Scalise]

    The IMX report also highlighted a sell-off among their clients in companies that experienced some friction during the month. Caterpillar Inc. (NYSE: CAT) was net sold as federal investigators continued their probe into the construction equipment company's export filings. Starbucks Corporation (NASDAQ: SBUX) was net sold as former CEO Howard Schultz prepared for his departure from the company in April.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was Caterpillar Inc. (NYSE: CAT) which traded up 2.10% at $94.21. The stock’s 52-week range is $69.04 to $99.46. Volume was about 20% below the daily average of around 5.2 million. The company was upgraded to Goldman Sachs’ Conviction Buy list this morning.

  • [By Ben Levisohn]

    Things were looking up for Caterpillar (CAT)–and then the Fed’s came a knockin’.

    Agence France-Presse/Getty Images

    Shares of Caterpillar had returned 7.1 percent so far this year–and 47% over the last 12 months–as optimism about the state of the global economy pushed its shares higher. But Caterpillar’s shares are tumbling this afternoon after reports that its offices in Peoria, Ill. and elsewhere were raided by Federal officers today.

    The Wall Street Journal’s Andrew Tangel reports:

    Agents from the Internal Revenue Service, the Federal Deposit Insurance Corp. and the U.S. Department of Commerce participated in the searches, according to a spokeswoman for the U.S. attorneys office for the Central District of Illinois.

    The U.S. attorneys spokeswoman said agents were at Caterpillar locations in Peoria, East Peoria and Morton, Ill. No arrests were made, the spokeswoman said.

    What are they investigating? No one seems to know as of yet, but I’m sure we will soon.

    Shares of Caterpillar have dropped 4.8% to $93.85 at 2:03 p.m. today.

what is share market: Warren Resources Inc.(WRES)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Warren Resources, Inc. (NASDAQ: WRES) were down 31 percent to $0.0656. Warren Resources filed for Chapter 11 bankruptcy.

    Gogo Inc (NASDAQ: GOGO) was down, falling around 15 percent to $9.40 after the company announced it has reached an agreement with American Airlines Group Inc (NASDAQ: AAL) to “continue to provide service on a meaningful portion of the American fleet currently served by Gogo.” Investors heavily sold off the stock as the company’s announcement implies it lost some orders to its main competitor, ViaSat, Inc. (NASDAQ: VSAT).

what is share market: Two Harbors Investments Corp(TWO)

Advisors’ Opinion:

  • [By David Hanson]

    This week at the Barclays Capital Global Financials Conference, droves of CEOs, CFOs, and CIOs trotted on stage to address a room full of eager analysts. One of the lone mREITs represented was Two Harbors (NYSE: TWO  ) . CEO Tom Siering and CIO Bill Roth weighed in on the current environment.

what is share market: 8×8 Inc(EGHT)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of 8×8 (NASDAQ:EGHT) rose 26.6% in 2016, according to data from S&P Global Market Intelligence.

    So what

    The provider of internet-based voice and communications services put together a remarkable financial record last year. 8X8 beat Wall Street’s earnings and sales estimates handily in each one of the year’s quarterly reports,citing strong organic revenue growth among larger customers along the way. Large-scale corporate customers accounted for 53% of the company’s total sales in the recently reported second quarter, and these big clients are also showing strong loyalty to the 8×8 brand by renewing their service contracts.

  • [By Lisa Levin]

    Telecommunications services shares climbed 0.56 percent in trading on Thursday. Meanwhile, top gainers in the sector included Frontier Communications Corp (NASDAQ: FTR), and 8×8, Inc. (NASDAQ: EGHT).

  • [By Peter Graham]

    A long term performance chart shows small cap magicJack VocalTec Ltd underperforming versus VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) which have been volatile, but have been heading higher:

  • [By Peter Graham]

    A long term performance chart shows small cap magicJack VocalTec Ltd hitting lower highs and lowerlows for some years now but also leveling off while VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) have been volatile, but also largely heading higher:

what is share market: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By James E. Brumley]

    Don’t be surprised if Lexaria Bioscience Corp (OTCMKTS:LXRP) shares seem a little peppier and even more bullish than usual for the next three months, give or take… and that’s saying something considering LXRP is 158% since early October, and up 47% since mid-December. Why’s that? The organization has hired a publicity firm to help tell its story to an even bigger audience, and that attention could attract a whole new batch of buyers for the stock.

    Granted, the Lexaria Bioscience story is a compelling one to begin with.

    If 2016 (and 2017 so far) were to be pegged with any major investment “themes,” cannabis would have to be it. Marijuana/hemp — cannabinoids, ultimately — was on the ballot for one reason or another in nine states this past November, and those pro-cannabis measures passed in eight of those votes. As such, cannabis is now legal for at least one reason in 26 states of the United States, and the movement is still gathering momentum.

    And well it should. The recreational aspect of marijuana and cannabinoids aside, hemp (a form of cannabis plant that isn’t the kind of marijuana that provides a “high”) delivers a multitude of health benefits. Specifically, users of hemp oil find the plant-based oil improves immunity, improves cardiovascular health, moderates blood sugar, treats skin conditions, treats arthritis, inhibits osteoporosis, fights some mental disorders, and in some cases has been found to be an anti-cancer agent. Lexaria Bioscience is simply enhancing these benefits of hemp oil by enhancing the amount of hemp oil a human body can absorb when ingested.

    Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. The key to the science is the fact that Lexaria Bioscience is able to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is it

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Jim Robertson]

    Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed:

  • [By James E. Brumley]

    Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

    The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

    Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”

    In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.

    The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.

    Hemp seeds (which are technically a nut and are als

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

automated stock trading

Mid-Con Energy Partners (MCEP) has seen its unit price fall around 30% since the beginning of June as oil prices have also fallen substantially during the past few weeks. I believe that Mid-Con could now nearly double from current levels, although there is significant risk involved. For Mid-Con to nearly double, it needs to avoid major difficulties with its credit facility lenders, start growing its production modestly again and also have the long-term price of oil go back up to around $50. While I believe that oil should generally gravitate to the $45 to $55 range over time, if oil is stuck at the low end of that range or below for the rest of 2017, that could cause problems for Mid-Con with its credit facility. Thus Mid-Con is both a bet on modestly higher long-term oil prices and a partial recovery that happens before October.

Limited Impact On Finances

Lower oil prices will only have a modest impact on Mid-Con’s finances during the rest of 2017. The difference between $44 oil (current strip) and $50 oil over the back half of 2017 for Mid-Con’s cash flow is around $1.4 million, as the decrease in oil revenue is significantly offset by hedges and production tax savings. Thus, Mid-Con’s credit facility borrowings are estimated to be a bit over $115 million at the end of 2017 based on strip prices now, versus $113.7 million when calculated from prices at the beginning of June.

automated stock trading: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

automated stock trading: Snap Inc. (SNAP)

Advisors’ Opinion:

  • [By Virendra Singh Chauhan]

    Shares of Menlo Park, California-based Facebook Inc. (NASDAQ:FB)have been on a solid run. FB stock closed the last trading session at a price of$139.92 per share, 0.8% lower than the previous close. While the stock is still up by nearly 22% for the year, the recent trade action saw the stock slip below a crucial support level. The closing price of$139.92 was the first time that FB stock closed below the $140 mark since March 23rd. On a more positive note, Facebook announced yet another shot aimed at Snap Inc (NYSE:SNAP) owned Snapchat. Having stepped up its battle against Snapchat with a flurry of strikes through its various social networks/communicationplatforms, the social networking giant delivered what could be the next major blow to Snap Inc (NYSE:SNAP) owned Snapchat. Given the mixed news around FB stock, should investors exit FB stock on the fall below an important support line? Or is this an opportunity to buy into a solid growth name, at lower valuation levels?

  • [By Virendra Singh Chauhan]

    Venice, California, based Snap Inc (NYSE:SNAP), parent of the popular photo-sharing app Snapchat has been listed on the NYSE for less than a week. In the week immediately following the Snap IPO, a number of Wall Street firms issued initial commentary on SNAP stock. And well, the Wall Street commentary has been far from encouraging for SNAP bulls. The latest to join this deluge of Wall Street chorus wasShebly Seyrafi fromFBN Securities, who believes that Facebook Inc (NASDAQ:FB) could be interested in buying out Snapchat. But Would the Menlo park, based Social Networking giant really consider making such a bid?

  • [By Virendra Singh Chauhan]

    Venice, California, based Snap Inc (NYSE:SNAP), owner of the popular photo sharing platform, ‘Snapchat’ has now been listed on the NYSE for a fortnight. The company’s life as a publicly listed company has been anything, but rosy. After opening at $24 on the IPO day, it has been all downhill for the newly listed company. Snap stock closed the last trading session at a price of $19.89, down over 17% from its IPO day open. This was also the first time the stock closed below the $20 mark following its IPO. With the SNAP stock price now approaching its IPO price of $17, what lies ahead for SNAP stock? Is it time to sell the stock? Or, have we hit the bottom?

  • [By Jack Delaney]

    After the March 2 Snap Inc. (NYSE: SNAP) IPO, anxious investors are waiting for the next big private company to go public. Retail investors assume they can make double-digit and triple-digit returns by buying into an IPO early.

  • [By Virendra Singh Chauhan]

    The life of Venice, California-basedSnap Inc. (NYSE:SNAP)as a public company can be best summarized as ‘short, volatile and eventful.’ SNAP stock hasseen huge volatility, rising from its IPO price of $17 to close its first trading day at $24.5 per share. After closing at a high of $27.09 on March 3rd, the stock fell all the way to sub-$20 levels before rising back to nearly $24. And, Snap stock price now hovers around the $20 mark, closing the last trading session at $20.8 per share (April 7). More importantly, the stock could fall below the psychologically crucial $20 mark, after multiple investment houses recently issued cautious to neutral commentary on the name.

automated stock trading: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By James E. Brumley]

    Don’t be surprised if Lexaria Bioscience Corp (OTCMKTS:LXRP) shares seem a little peppier and even more bullish than usual for the next three months, give or take… and that’s saying something considering LXRP is 158% since early October, and up 47% since mid-December. Why’s that? The organization has hired a publicity firm to help tell its story to an even bigger audience, and that attention could attract a whole new batch of buyers for the stock.

    Granted, the Lexaria Bioscience story is a compelling one to begin with.

    If 2016 (and 2017 so far) were to be pegged with any major investment “themes,” cannabis would have to be it. Marijuana/hemp — cannabinoids, ultimately — was on the ballot for one reason or another in nine states this past November, and those pro-cannabis measures passed in eight of those votes. As such, cannabis is now legal for at least one reason in 26 states of the United States, and the movement is still gathering momentum.

    And well it should. The recreational aspect of marijuana and cannabinoids aside, hemp (a form of cannabis plant that isn’t the kind of marijuana that provides a “high”) delivers a multitude of health benefits. Specifically, users of hemp oil find the plant-based oil improves immunity, improves cardiovascular health, moderates blood sugar, treats skin conditions, treats arthritis, inhibits osteoporosis, fights some mental disorders, and in some cases has been found to be an anti-cancer agent. Lexaria Bioscience is simply enhancing these benefits of hemp oil by enhancing the amount of hemp oil a human body can absorb when ingested.

    Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. The key to the science is the fact that Lexaria Bioscience is able to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is it

  • [By Bryan Murphy]

    When you’ve come up with a technology that increases the digestion of minerals, vitamins, compounds, nutrients, and even medicine, the first thing you want to do is protect that idea so nobody else can commercialize it except you. Well, Lexaria Bioscience Corp (OTCMKTS:LXRP) has figured out how to do the former, and it’s been doing the latter… in spades. First it started by building a wall around its platform in the United States, but as of today’s press release is building a wall internationally as well.

    It’s an exciting prospect to be sure. In simplest terms, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s largely unrecognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes the game, so to speak. How? A proprietary process that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    The science: Lexaria Bioscience has defined a way to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is itself lipid based, making this format the easiest and most effective means of introducing the medicinal and health benefits of hemp and hemp oil.

    And the results have been impressive in two different studies

  • [By Bryan Murphy]

    Though they’re not the same thing, anything that’s good for marijuana is good for hemp. That’s why when eight out of nine states that had marijuana on the ballot two Tuesday’s ago approved those measures, things got a lot more compelling for owner of Lexaria Bioscience Corp (OTCMKTS:LXRP).

    What’s the difference? Hemp a strains of Cannabis sativa that have been bred specifically for fiber used for clothing, construction, oils and topical ointments, nutritional benefits and a wide array of other purposes that don’t involve getting “high.” Marijuana is a slang term used to describe strains of Cannabis sativa that are bred for the potent resinous glands, or trichomes, that grow on the flowers and some leaves… the strain packed with tetrahydrocannabinol (or THC).

    They would be easy to confuse, and commonly are. The potential for confusion, in fact, is the chief reason government agencies have been hesitant to support one and ban the other. With marijuana now legalized for use for one reason or another in more than half the United States though, knowledge and understanding of the difference will soon follow.

    Great, but what’s that got to do with Lexaria Bioscience is on the leading edge of the movement of heightened understanding of what hemp is, and what it does.

    The medical benefits of the non-psychoactive form of Cannabis sativa are impressive to say the least. Among other benefits, hempseed oil has also shown a positive effect on dermatological diseases and lipid metabolism (the process by which fatty acids are broken down in the body). Hempseed also has high levels of vitamins A, C and E and ?-carotene, and it is rich in minerals like phosphorus, potassium, magnesium, sulfur and calcium. As a food, hempseed oil is nutritious – it contains an excellent balance of polyunsaturated fatty acids – and it reportedly tastes good, too.

    Problem: Hemp isn’t effectively absorbed into the body, and as such, it’s difficult to make effec

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

automated stock trading: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Monday, cyclical consumer goods & services shares gained by 0.41 percent. Top gainers in the sector included Kandi Technologies Group Inc (NASDAQ: KNDI), Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT), and Lifetime Brands Inc (NASDAQ: LCUT).

automated stock trading: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedbuying small cap performance improvement stock GSE Systems (NYSEMKT: GVP):

    GSE Systems is another somewhat-preemptive position; we think the recent support at the 100-day moving average line (gray) and subsequent string of higher lows is telling. There’s a ceiling at $3.27 that needs to be cleared, but we fear waiting on that to happen because once it does, GVP shares could be catapulted to a price we don’t want to chase.

automated stock trading: Diamondrock Hospitality Company(DRH)

Advisors’ Opinion:

  • [By Monica Gerson]

    DiamondRock Hospitality Company (NYSE: DRH) is projected to post its quarterly earnings at $0.18 per share on revenue of $218.42 million.

    Weyerhaeuser Co (NYSE: WY) is expected to report its quarterly earnings at $0.20 per share.

stock market today chart

It’s busy season for immigration lawyers. On April 3, people can start submitting H-1B visa petitions for the new fiscal year.

The popular visa, beloved by the tech industry, is a pathway for skilled foreigners to work in the U.S.

It’s in high demand: Last year, the cap of 85,000 H-1B visas was reached less than a week after the application period opened up. During that time, 236,000 petitions were submitted.

When demand exceeds supply, the visas are awarded through a lottery system.

And this year, there are additional stress factors: The political environment is decidedly less welcoming to foreigners and one of the favored processing options has been put on hold.

For an additional $1,225 fee, premium processing guarantees that an H-1B petition is reviewed within 15 days (if it’s selected in the lottery). According to USCIS, premium processing filings accounted for 59% of the total H-1B filings in 2016. But in March, USCIS announced it was temporarily freezing that option on April 3.

stock market today chart: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

  • [By Ben Levisohn]

    Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.

    Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.

stock market today chart: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By Jim Robertson]

    Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

stock market today chart: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

stock market today chart: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Lisa Levin]

    Rent-A-Center Inc (NASDAQ: RCII) was down, falling around 26 percent to $9.88. Rent-A-Center reported upbeat quarterly earnings, but the company’s sales missed analysts’ estimates.

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

stock market today chart: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Gold Stocks To Own For 2018

This summer has been arguably the quietest and least volatile for the U.S. markets, but that hasn’t kept investors from making money. Ask the fund managers who study precious metals and emerging markets, they are sure to agree.

During the fourteen-week period between the Memorial Day and the Labor Day, better known as the “sell in May and go away” period, mutual funds from the aforementioned categories returned around 20% this year. Such a staggeringly high return was possible mostly due to low interest rates, which benefits such asset classes. Emerging markets have also seen dramatic GDP growth this year, while fears of an economic downturn in China have ebbed.

Gold-Focused Mutual Funds Glitter

Weak global economic scenario coupled with Brexit induced volatility compelled the Fed to keep rates low in the short term. Add to this, weak service sector growth, contraction in manufacturing activity and slowdown in pace of hiring in August, and we all know that the Fed may not hike rates any time soon.

Top 10 Gold Stocks To Own For 2018: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By Monica Gerson] Related CSC Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Computer Sciences' (CSC) CEO Mike Lawrie on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise … (GuruFocus)

    Some of the stocks that may grab investor focus today are:

  • [By R. Chandrasekaran]

    Some of the outperforming stocks:

    NVDIA Corp (NASDAQ: NVDA) trading up about 5.7 percent with a range between $69.50 and $71.72.
    Amazon.com, Inc. (NASDAQ: AMZN) is gaining about 4 percent. The stock ranged between $770.94 and $787.73.
    Computer Sciences Corporation (NYSE: CSC) is gaining about 3.3 percent with the stock trading between $56.10 and $58.01.
    Microsoft Corporation (NASDAQ: MSFT) is adding about 3 percent with the stock ranging $59.78-$60.52.
    Alphabet Inc (NASDAQ: GOOGL) is gaining about 2.9 percent with the stock trading between $792.90 and $805.
    Intel Corporation (NASDAQ: INTC) is adding approximately 2.9 percent with shares trading in the range of $34.15-$34.60.
    Cisco Systems, Inc. (NASDAQ: CSCO) is gaining about 2.8 percent as the stock traded between $30.61 and $31.05.
    Salesforce.com, inc. (NYSE: CRM) is adding about 2.8 percent with the shares traded in the range of $75.41-$77.00

Top 10 Gold Stocks To Own For 2018: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 10 Gold Stocks To Own For 2018: Reliance Steel & Aluminum Co.(RS)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    This is mostly triggered by artificial boosts in steel prices caused by trade regulation. Rising costs are positive for the steel industry and players like United States Steel Corporation (NYSE: X), AK Steel Holding Corporation (NYSE: AKS) and Reliance Steel & Aluminum Co (NYSE: RS), but they’re ultimately injurious to those reliant on steel products manufacturers of canned goods, farm equipment, machinery and appliances.

Top 10 Gold Stocks To Own For 2018: Terex Corporation(TEX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Terex (TEX) had surged 32% as of the close of trading last Thursday–but dropped 14% the next day after China’s Zoomlion announced that it wouldn’t be pursuing a purchase of the U.S. crane maker after all. In the aftermath of the scuttled deal, Morgan Stanley’s Mili Pothiwala and Nigel Coe cut Terex to Equal Weight from Overweight:

    Balint Porneczi/Bloomberg News

    On Friday morning, Zoomlion announced it had terminated its bid for its proposed acquisition of Terex for $31/ share. This was a clear negative for Terex shares, which traded down ~15% on Friday to $20, given the absence of an event-driven catalyst (following the sale of MHPS to Konecranes, which we assume will be completed). However, we think that the stock’s current discount to the Machinery group on a P/E basis (20%+) is justified, given a still challenged underlying operating environment for the RemainCo, as well as historically uneven company execution – both of which return to the forefront of the investment debate following the removal of the M&A bull case.

    To which all we can say is: Oops.

    Shares of Terex have dropped 0.5% to $20.78

     

  • [By Ben Levisohn]

    Third and a trigger for the change: China becomes an active bidder in the space. Chinas Zoomlion bid for Terex (TEX) ($3.3B) along with Haier/General Electric (GE) ($5.4B) and several ChemChina proposed deals in industrials changes the upside/downside skew, particularly on lower quality/more challenged names. The Terex bid does not appear to be one-off. Chinese outbound M&A announcements rose to record highs in 15; to $112B (up 57% from 2014) in total acquisitions. Industrials formed a large and rising portion, at ~12B completed. Thats roughly equal to the 3 prior years industrials deals combined, and is the highest on record. Energy and materials accounted for ~15% of 15 spend vs. ~83% in 2011. Even lower quality or more currently challenged machinery franchises have distribution which could be highly attractive to new entrants…

  • [By Ben Levisohn]

    RBC’sSeth Weber and team offer their thoughts on Zoomlion’s revised bid for Terex (TEX):

    Bloomberg News

    After the close today, Terex announced that it is moving forward in its negotiations with Zoomlion Heavy Industry Science and Technology Co. following receipt of a non-binding proposal from the Chinese company to acquire all outstanding shares for $31/share in cash.

  • [By Ben Levisohn]

    Yesterday, Terex (TEX) announced that it would sell its ports business to Konecranes for $1.3 billion. Today, Baird’s Mircea Dobre and Joseph Grabowski upgraded Terex to Outperform from Neutral, arguing that the sale makes a takeover by China’s Zoomlion that much easier. They explain:

    Balint Porneczi/Bloomberg News

    The sale of MHPS to Konecranes is a positive catalyst on multiple fronts: shareholders got an attractive multiple for what historically has been a challenged business with further upside possible given 25% equity ownership in Konecranes, execution risk is diminished as new CEO can focus on operational improvement without the effort required to integrate the Terex and Konecranes businesses, and finally, the MHPS sale makes it easier for Zoomlion to acquire remaining Terex.

    While our upgrade is not reliant on Zoomlion acquiring Terex, the MHPS transaction could make a firm Zoomlion offer more likely.

    At the margin, a Zoomlion deal appears easier to get done: 1) the remaining businesses fit better with Zoomlions existing product portfolio of construction equipment, cranes, and various commercial and municipal equipment, 2) given the attractive terms of the MHPS sale, the funding hurdle required to acquire Terex is lowered, 3) many of the CFIUS issues center around national security concerns regarding the nations ports, no longer a concern given MHPS sale.

    Dobre and Grabowski also raised their price target on Terex to $30, up from $24. With Terex off 0.1% at $24.88 today, that leaves 21% upside in the stock to Baird’s target.

    In February, I wrote about Chinese demand for U.S. companies, including Terex.

  • [By Reuben Gregg Brewer]

    Ever walk past a construction site? It’s hard not to be enthralled by all the heavy construction machinery moving things around. With the world’s developing economies still building at a relatively fast pace and developing economies, like the United States, in desperate need of upgrading their aging infrastructure, the companies behind that construction machinery could be just as exciting as a construction site in the years ahead. Which is why Caterpillar Inc. (NYSE:CAT), Cummins Inc. (NYSE:CMI), and Terex Corporation (NYSE:TEX) are three of the top construction machinery stocks to look at right now.

Top 10 Gold Stocks To Own For 2018: Aaron's, Inc.(AAN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Align Technology, Inc. (NASDAQ: ALGN) and Aaron's, Inc. (NYSE: AAN).

  • [By Peter Graham]

    Just this morning, small cap consumer electronics retailer Aaron’s, Inc (NYSE: AAN) reported first quarter earnings that have beat expectations. First quarter revenues were$844.6 million compared with $854.4 million for the first quarter of 2016 whilenet earnings increased to $53.3 million compared with $49.7 million in the prior year period. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co now outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

Top 10 Gold Stocks To Own For 2018: Sagent Pharmaceuticals Inc.(SGNT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) got a boost, shooting up 40 percent to $21.65 as the company agreed to be acquired by Nichi-Iko Pharmaceutical for $21.75 per share. RBC Capital downgraded Sagent Pharmaceuticals from Outperform to Sector Perform.

Top 10 Gold Stocks To Own For 2018: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo, Tyler Crowe, and Jason Hall]

    Oil prices haven’t gotten off to the fast start many expected, falling around 6% on average during the first quarter of the year. That slump came despite OPEC’s best efforts since producing nations have achieved fairly good compliance on their planned output cuts. That said, despite the lackluster oil market, we still see some interestingopportunities in the oil market. Three stocks we really like right now are DistributionNOW(NYSE:DNOW),Phillips 66(NYSE:PSX), andConocoPhillips(NYSE:COP), which all should do well in the current oil market.

  • [By Dustin Parrett]

    Big Oil stocks are the seven “oil supermajors” that do everything from oil drilling to refining to retail sales. This is a list of the Big Oil companies:

    Big Oil CompanyShare PriceYTDMarket CapExxon Mobil Corp. (NYSE: XOM)$83.44-7.58%$353.13BChevron Co. (NYSE: CVX)$113.56-3.5%$217.62BConocoPhillips Co. (NYSE: COP)$48.21-3.78%$61.42BRoyal Dutch Shell Plc. (NYSE ADR: RDS.A)$52.35-3.82%$221.08BBP Plc. (NYSE ADR: BP)$34.12-8.71%$112.69BTotal SA (NYSE: TOT)$50.26-1.35%$124.6BEni SpA (NYSE: E)$31.51-2.3%$58.69B

    Despite being huge global oil companies, shares of Big Oil stocks are all in the red this year. Those losses have all happened even as the Dow is smashing record highs and trading up 6.4% year to date.

  • [By Jon C. Ogg]

    Things have improved handily from a year ago in the energy sector. Still, even with a pro-energy White House, things are far from perfect in the oil and gas sector. Now ConocoPhillips (NYSE: COP) is delivering great news to its shareholders.

Top 10 Gold Stocks To Own For 2018: Green Mountain Coffee Roasters Inc.(GMCR)

Advisors’ Opinion:

  • [By Jonas Elmerraji]

    As badly as short sellers want to hate on Green Mountain Coffee Roasters (GMCR), betting against the multiyear rally in this $12.7 billion beverage stock has been about as wise as eating from a box with a skull and crossbones on it. And as a bull market continues to lift all ships, Green Mountain’s ship is going to keep floating above the others.

    Green Mountain owns Keurig, the brand of beverage brewers that use self-contained K-Cups to make coffee, teas, and other drinks. While Keurig’s “fad” status has certainly helped tip the deck against GMCR, the fact remains that the firm has done most of the hard work in getting Keurig machines accepted by consumers. With brewers essentially ubiquitous at this point, the firm is able to make money on its cash cow: the K-Cups.

    Keurig’s individual-serving cups have big margins and a big installed base. With huge convenience and the relatively large sunk cost that consumers have put into their Keurig machines, it’s a sticky business with big switching costs. Consumers who buy a Keurig are much less likely to spend the money on a competing brand of proprietary coffee pods.

    I’ve said before that GMCR is far from cheap right now. But its momentum trajectory is showing few signs of fizzling out, especially as direct competitors such as Starbucks (SBUX) continue to sell K-Cups of their own. Don’t bet against GMCR in September – buy this Rocket Stock instead.

  • [By Canadian Value]

    So Im going to stick my next out and share my views on four battleground stocks that are among my favorite shorts: World Acceptance (WRLD), Green Mountain (GMCR), Herbalife (HLF), and InterOil (IOC). And next week at the Value Investing Congress I will present another short, my largest.

  • [By David Sterman]

    But for short sellers in Green Mountain Coffee Roasters (Nasdaq: GMCR), there's another outcome: They've been badly burned as shares have surged, but they insist they've been right all along, and it's only a matter of time before the stock crashes and burns.

Top 10 Gold Stocks To Own For 2018: Coeur d’Alene Mines Corporation(CDE)

Advisors’ Opinion:

  • [By Manikandan Raman]

    Citing bullish outlook on silver prices, Peter Bures of Canaccord Genuity has started coverage of four silver producers: Pan American Silver Corp. (USA) (NASDAQ: PAAS), Coeur Mining Inc (NYSE: CDE), Hecla Mining Company (NYSE: HL), and Endeavour Silver Corp (NYSE: EXK). The brokerage also assumed coverage of Fortuna Silver Mines Inc (NYSE: FSM) with a Buy rating.

  • [By Dan Caplinger]

    Still, some stocks managed to buck the negative sentiment on Tuesday, and Sears Holdings (NASDAQ:SHLD), Plug Power (NASDAQ:PLUG) and Coeur Mining (NYSE:CDE) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Ben Levisohn]

    Given revised commodity deck forecasts (particularly for Steel and Gold) and improved Balance Sheet health (Steels, Precious and Industrials Metals) we are upgrading our ratings on several stocks in our coverage. We generally favor companies that have already initiated specific self-help, have low-cost assets and are less exposed to China supply and demand dynamics. In Steels, we have increased our rating from Hold to Buy on Nucor (NUE) and from Sell to Hold on US Steel. We have also upgraded Kinross Gold (KGC) to a Hold on valuation…On higher-than-peer valuations, we reiterate Sell-rated Coeur Mining (CDE), Franco-Nevada (FNV), Goldcorp (GG), Teck Resources (TCK) and highly leveraged AK Steel given preference to issue further equity if possible.

  • [By Ben Levisohn]

    Deutsche Bank’s Jorge Beristain and Chris Terry released their earnings preview for the gold miners–including Barrick Gold (ABX), Goldcorp (GG), Franco-Nevada (FNV), and Coeur Mining (CDE)–and conclude that only one gold miner deserves a Buy rating: Newmont Mining (NEM). They explain why:

Top 10 Gold Stocks To Own For 2018: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    Though they’re not the same thing, anything that’s good for marijuana is good for hemp. That’s why when eight out of nine states that had marijuana on the ballot two Tuesday’s ago approved those measures, things got a lot more compelling for owner of Lexaria Bioscience Corp (OTCMKTS:LXRP).

    What’s the difference? Hemp a strains of Cannabis sativa that have been bred specifically for fiber used for clothing, construction, oils and topical ointments, nutritional benefits and a wide array of other purposes that don’t involve getting “high.” Marijuana is a slang term used to describe strains of Cannabis sativa that are bred for the potent resinous glands, or trichomes, that grow on the flowers and some leaves… the strain packed with tetrahydrocannabinol (or THC).

    They would be easy to confuse, and commonly are. The potential for confusion, in fact, is the chief reason government agencies have been hesitant to support one and ban the other. With marijuana now legalized for use for one reason or another in more than half the United States though, knowledge and understanding of the difference will soon follow.

    Great, but what’s that got to do with Lexaria Bioscience is on the leading edge of the movement of heightened understanding of what hemp is, and what it does.

    The medical benefits of the non-psychoactive form of Cannabis sativa are impressive to say the least. Among other benefits, hempseed oil has also shown a positive effect on dermatological diseases and lipid metabolism (the process by which fatty acids are broken down in the body). Hempseed also has high levels of vitamins A, C and E and ?-carotene, and it is rich in minerals like phosphorus, potassium, magnesium, sulfur and calcium. As a food, hempseed oil is nutritious – it contains an excellent balance of polyunsaturated fatty acids – and it reportedly tastes good, too.

    Problem: Hemp isn’t effectively absorbed into the body, and as such, it’s difficult to make effec

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

  • [By Jim Robertson]

    Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed: